insights_auto
Why is ANTX down 2.20%?
Dive Deeperchevron_right
ANTX:NASDAQ
AN2 Therapeutics Inc
$4.90
arrow_downward
-2.20%(-0.11) 1D
Sep 29, 11:25:08 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANTX...
Open
$4.99
High
$5.03
Low
$4.76
Mkt. cap
184.91M
Avg. vol.
234.67K
Volume
46.46K
52-wk high
$7.19
52-wk low
$1.00
EPS
-$1.07
Beta
-0.99
Shares outstanding
37.74M
No. of employees
21
Open
$4.99
High
$5.03
Low
$4.76
Mkt. cap
184.91M
Avg. vol.
234.67K
Volume
46.46K
52-wk high
$7.19
52-wk low
$1.00
EPS
-$1.07
Beta
-0.99
Shares outstanding
37.74M
No. of employees
21
News stories
From web sources and news partners
Stock Titan
·
1 day ago
AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
https://www.dars.gov.et/
·
2 months ago
ANTX Q1 2026 Earnings: EPS Misses Estimates as Pre-Commercial Biotech Reports No Revenue - Earnings Surprise Stocks
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, California, United States
SectorPharmaceutical industry
Websitean2therapeutics.com